BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 14604958)

  • 41. The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia.
    Van Vlierberghe P; van Grotel M; Beverloo HB; Lee C; Helgason T; Buijs-Gladdines J; Passier M; van Wering ER; Veerman AJ; Kamps WA; Meijerink JP; Pieters R
    Blood; 2006 Nov; 108(10):3520-9. PubMed ID: 16873670
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The NUP98-HOXD13 fusion oncogene induces thymocyte self-renewal via Lmo2/Lyl1.
    Shields BJ; Slape CI; Vo N; Jackson JT; Pliego-Zamora A; Ranasinghe H; Shi W; Curtis DJ; McCormack MP
    Leukemia; 2019 Aug; 33(8):1868-1880. PubMed ID: 30700838
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The SCL complex regulates c-kit expression in hematopoietic cells through functional interaction with Sp1.
    Lécuyer E; Herblot S; Saint-Denis M; Martin R; Begley CG; Porcher C; Orkin SH; Hoang T
    Blood; 2002 Oct; 100(7):2430-40. PubMed ID: 12239153
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assembly of the oncogenic DNA-binding complex LMO2-Ldb1-TAL1-E12.
    Ryan DP; Duncan JL; Lee C; Kuchel PW; Matthews JM
    Proteins; 2008 Mar; 70(4):1461-74. PubMed ID: 17910069
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modeling T-cell acute lymphoblastic leukemia induced by the SCL and LMO1 oncogenes.
    Tremblay M; Tremblay CS; Herblot S; Aplan PD; Hébert J; Perreault C; Hoang T
    Genes Dev; 2010 Jun; 24(11):1093-105. PubMed ID: 20516195
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Defects of the mismatch repair gene MSH2 are implicated in the development of murine and human lymphoblastic lymphomas and are associated with the aberrant expression of rhombotin-2 (Lmo-2) and Tal-1 (SCL).
    Lowsky R; DeCoteau JF; Reitmair AH; Ichinohasama R; Dong WF; Xu Y; Mak TW; Kadin ME; Minden MD
    Blood; 1997 Apr; 89(7):2276-82. PubMed ID: 9116269
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical features and outcome of T-cell acute lymphoblastic leukemia in childhood with respect to alterations at the TAL1 locus: a Pediatric Oncology Group study.
    Bash RO; Crist WM; Shuster JJ; Link MP; Amylon M; Pullen J; Carroll AJ; Buchanan GR; Smith RG; Baer R
    Blood; 1993 Apr; 81(8):2110-7. PubMed ID: 8471769
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A previously unrecognized promoter of LMO2 forms part of a transcriptional regulatory circuit mediating LMO2 expression in a subset of T-acute lymphoblastic leukaemia patients.
    Oram SH; Thoms JA; Pridans C; Janes ME; Kinston SJ; Anand S; Landry JR; Lock RB; Jayaraman PS; Huntly BJ; Pimanda JE; Göttgens B
    Oncogene; 2010 Oct; 29(43):5796-808. PubMed ID: 20676125
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The basic helix-loop-helix transcription factor TAL1/SCL inhibits the expression of the p16INK4A and pTalpha genes.
    Hansson A; Manetopoulos C; Jönsson JI; Axelson H
    Biochem Biophys Res Commun; 2003 Dec; 312(4):1073-81. PubMed ID: 14651981
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transcriptional activation by TAL1 and FUS-CHOP proteins expressed in acute malignancies as a result of chromosomal abnormalities.
    Sánchez-García I; Rabbitts TH
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):7869-73. PubMed ID: 8058726
    [TBL] [Abstract][Full Text] [Related]  

  • 51. microRNAs regulate TAL1 expression in T-cell acute lymphoblastic leukemia.
    Correia NC; Melão A; Póvoa V; Sarmento L; Gómez de Cedrón M; Malumbres M; Enguita FJ; Barata JT
    Oncotarget; 2016 Feb; 7(7):8268-81. PubMed ID: 26882564
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Growth inhibition and apoptosis due to restoration of E2A activity in T cell acute lymphoblastic leukemia cells.
    Park ST; Nolan GP; Sun XH
    J Exp Med; 1999 Feb; 189(3):501-8. PubMed ID: 9927512
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The DNA binding activity of TAL-1 is not required to induce leukemia/lymphoma in mice.
    O'Neil J; Billa M; Oikemus S; Kelliher M
    Oncogene; 2001 Jun; 20(29):3897-905. PubMed ID: 11439353
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences.
    van Grotel M; Meijerink JP; van Wering ER; Langerak AW; Beverloo HB; Buijs-Gladdines JG; Burger NB; Passier M; van Lieshout EM; Kamps WA; Veerman AJ; van Noesel MM; Pieters R
    Leukemia; 2008 Jan; 22(1):124-31. PubMed ID: 17928886
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Disordered T-cell development and T-cell malignancies in SCL LMO1 double-transgenic mice: parallels with E2A-deficient mice.
    Chervinsky DS; Zhao XF; Lam DH; Ellsworth M; Gross KW; Aplan PD
    Mol Cell Biol; 1999 Jul; 19(7):5025-35. PubMed ID: 10373552
    [TBL] [Abstract][Full Text] [Related]  

  • 56. TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia.
    Baer R
    Semin Cancer Biol; 1993 Dec; 4(6):341-7. PubMed ID: 8142619
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Deregulated expression of the TAL1 gene by t(1;5)(p32;31) in patient with T-cell acute lymphoblastic leukemia.
    François S; Delabesse E; Baranger L; Dautel M; Foussard C; Boasson M; Blanchet O; Bernard O; Macintyre EA; Ifrah N
    Genes Chromosomes Cancer; 1998 Sep; 23(1):36-43. PubMed ID: 9713995
    [TBL] [Abstract][Full Text] [Related]  

  • 58. scid Thymocytes with TCRbeta gene rearrangements are targets for the oncogenic effect of SCL and LMO1 transgenes.
    Chervinsky DS; Lam DH; Melman MP; Gross KW; Aplan PD
    Cancer Res; 2001 Sep; 61(17):6382-7. PubMed ID: 11522630
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of the leukemia oncogene Lmo2 is controlled by an array of tissue-specific elements dispersed over 100 kb and bound by Tal1/Lmo2, Ets, and Gata factors.
    Landry JR; Bonadies N; Kinston S; Knezevic K; Wilson NK; Oram SH; Janes M; Piltz S; Hammett M; Carter J; Hamilton T; Donaldson IJ; Lacaud G; Frampton J; Follows G; Kouskoff V; Göttgens B
    Blood; 2009 Jun; 113(23):5783-92. PubMed ID: 19171877
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Helix-loop-helix (E2-5, HEB, TAL1 and Id1) protein interaction with the TCRalphadelta enhancers.
    Bernard M; Delabesse E; Smit L; Millien C; Kirsch IR; Strominger JL; Macintyre EA
    Int Immunol; 1998 Oct; 10(10):1539-49. PubMed ID: 9796921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.